Company: BSX
Filing Date: 2025-03-19
Form Type: DEF 14A
Source: 0000885725-25-000017
Chunk: 74

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-03-19
Form: DEF 14A
Chunk 74
---
 | $ |  3,600,000 |
| Jeffrey B. Mirviss   |     |                                      |     |  8,462 |     |                                      |  8,462 |     |                 |     |  22,311 |     |                      |     |  8,462 |     |                                               |     | $ |  2,200,000 |

(1) Our NEOs’ 2024 long-term incentive awards were granted on February 12, 2024. The stock options have an exercise price of $64.99 per share, the closing price of our common stock on the date of grant.

(2) Total Long-Term Incentive Award Target Value is rounded to the nearest thousand. Mr. Mahoney’s 2024 Total Long-Term Incentive Award Target Value was meaningfully increased in recognition of his performance and to bring his compensation in line with similarly situated executives in the Company’s peer group.

The number of ONSG and rTSR performance-based RSUs and service-based RSUs were calculated by dividing the target dollar value of those awards by the closing price of our common stock on the date of grant, and the numbers of stock options were determined by dividing the target dollar value of that award by the stock option value determined in accordance with FASB ASC Topic 718 Stock Compensation , as described in the footnotes to the Summary Compensation Table on page 72 .

#### 642025 Proxy Statement

### Compensation Discussion & Analysis
Company Performance-Based RSUs — Results for Performance Period ended
December 31, 2024

In February 2025, our Compensation Committee determined the number of RSUs earned pursuant to our performance-based RSUs under the 2022 rTSR PSP presented in the table below. In commitment to our pay-for-performance philosophy, 200% of shares were awarded under our 2022 rTSR PSP based on performance for the three-year period ended December 31, 2024.

| Grant Year |     | Performance Metric                                                                 |     |                                                                      Achievement |     |                NEO |     |             RSUs Earned based 
 on Achievement of Performance 
                           (#) |
| 2022       |     | rTSR Percentile Performance Rank for the three-year period ended December 31, 2024 |     | 93rdpercentile rank relative to other companies in the S&P 500 Health Care Index 
                                 200%of target rTSR performance-based RSUs earned